secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2026-08-19T21:00:16+00:00
Accession:  0001193125-26-357087
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TuHURA stockholders approve 1.88M share issuance to Parkview; six directors elected
--------------------------------------------------------------------------------

- Stockholders approved issuance of 1,878,287 shares to Parkview Holdings One LLC as loan fee under $50M revolving credit facility (Loan Agreement dated April 21, 2026).
- Nasdaq Proposal vote: 28,128,581 for / 517,896 against; shares issued to accredited investor under Section 4(a)(2)/Reg D exemption.
- Six directors elected to 2027 term: James Bianco, James Manuso, Alan List, Margaret Ng, Robert E. Hoffman, Craig Tendler.
- Advisory say-on-pay approved (26,125,280 for); three-year frequency favored (14,472,967 votes).
- Cherry Bekaert LLP ratified as FY2026 independent auditor (42,911,888 for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000119312526357087/0001193125-26-357087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000119312526357087/hura-20260818.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-357087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer